# Alkermes plc. (ALKS) FY2026 Q2 Balance Sheet

- Company: Alkermes plc. (ALKS)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0001193125-26-319022
- Page: https://plicit.ai/financials/alks/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/alks-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 4,393,125,000 US dollars
- **Current assets**: 1,522,906,000 US dollars
- **Non-current assets**: 2,870,219,000 US dollars
- **Liabilities**: 2,584,575,000 US dollars
- **Current liabilities**: 662,091,000 US dollars
- **Non-current liabilities**: 1,922,484,000 US dollars
- **Equity**: 1,808,550,000 US dollars
- **Cash and cash equivalents**: 511,529,000 US dollars
- **Receivables, net**: 456,477,000 US dollars
- **Inventory**: 298,957,000 US dollars
- **Investments—short-term**: 145,048,000 US dollars
- **Prepaid expenses and other current assets**: 110,895,000 US dollars
- **Restricted cash**: 0 US dollars
- **INTANGIBLE ASSETS, NET**: 1,761,456,000 US dollars
- **GOODWILL**: 594,273,000 US dollars
- **PROPERTY, PLANT AND EQUIPMENT, NET**: 218,284,000 US dollars
- **DEFERRED TAX ASSETS**: 123,041,000 US dollars
- **RIGHT-OF-USE ASSETS**: 76,111,000 US dollars
- **OTHER ASSETS**: 62,000,000 US dollars
- **INVESTMENTS—LONG-TERM**: 35,054,000 US dollars
- **Accounts payable and accrued expenses**: 332,469,000 US dollars
- **Accrued sales discounts, allowances and reserves**: 295,645,000 US dollars
- **Current portion of long-term debt**: 26,500,000 US dollars
- **Operating lease liabilities—short-term**: 7,477,000 US dollars
- **LONG-TERM DEBT**: 1,476,611,000 US dollars
- **DEFERRED TAX LIABILITIES**: 179,575,000 US dollars
- **CONTINGENT CONSIDERATION**: 136,304,000 US dollars
- **OTHER LONG-TERM LIABILITIES**: 68,018,000 US dollars
- **OPERATING LEASE LIABILITIES—LONG-TERM**: 61,976,000 US dollars
- **Additional paid-in capital**: 3,112,920,000 US dollars
- **Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 184,700,718 and 181,011,166 shares issued; and 167,541,198 and 165,607,028 shares outstanding at June 30, 2026 and December 31, 2025, respectively**: 1,847,000 US dollars
- **Accumulated deficit**: negative 800,773,000 US dollars
- **Treasury shares, at cost (17,159,520 and 15,404,138 shares at June 30, 2026 and December 31, 2025, respectively)**: negative 502,521,000 US dollars
- **Accumulated other comprehensive loss**: negative 2,923,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
